
Cecilia M. Jaisle
Examiner (ID: 4742)
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1624 |
| Total Applications | 688 |
| Issued Applications | 442 |
| Pending Applications | 1 |
| Abandoned Applications | 246 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8232842
[patent_doc_number] => 08198282
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-12
[patent_title] => 'Substituted azaquinazolines having an antiviral action'
[patent_app_type] => utility
[patent_app_number] => 12/647210
[patent_app_country] => US
[patent_app_date] => 2009-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10459
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/198/08198282.pdf
[firstpage_image] =>[orig_patent_app_number] => 12647210
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/647210 | Substituted azaquinazolines having an antiviral action | Dec 23, 2009 | Issued |
Array
(
[id] => 8621491
[patent_doc_number] => 08354405
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-15
[patent_title] => '6-cycloamino-3-(pyrid-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof'
[patent_app_type] => utility
[patent_app_number] => 12/647059
[patent_app_country] => US
[patent_app_date] => 2009-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27983
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12647059
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/647059 | 6-cycloamino-3-(pyrid-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof | Dec 23, 2009 | Issued |
Array
(
[id] => 7511684
[patent_doc_number] => 20110257394
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-20
[patent_title] => 'CRYSTALS OF HYDROCHLORIDE OF PYRIDAZIN-3(2H)-ONE COMPOUND AND PROCESS FOR PRODUCTION OF SAME'
[patent_app_type] => utility
[patent_app_number] => 13/142114
[patent_app_country] => US
[patent_app_date] => 2009-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4431
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20110257394.pdf
[firstpage_image] =>[orig_patent_app_number] => 13142114
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/142114 | Crystals of hydrochloride of pyridazin-3(2H)-one compound and process for production of same | Dec 21, 2009 | Issued |
Array
(
[id] => 6455146
[patent_doc_number] => 20100105692
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-29
[patent_title] => 'Dipterinyl Calcium Pentahydrate (DCP) and Therapeutic Methods Based Thereon'
[patent_app_type] => utility
[patent_app_number] => 12/643752
[patent_app_country] => US
[patent_app_date] => 2009-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7522
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20100105692.pdf
[firstpage_image] =>[orig_patent_app_number] => 12643752
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/643752 | Dipterinyl Calcium Pentahydrate (DCP) and Therapeutic Methods Based Thereon | Dec 20, 2009 | Abandoned |
Array
(
[id] => 8577763
[patent_doc_number] => 08343973
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-01
[patent_title] => 'Phenoxymethyl heterocyclic compounds'
[patent_app_type] => utility
[patent_app_number] => 12/642026
[patent_app_country] => US
[patent_app_date] => 2009-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24825
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12642026
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/642026 | Phenoxymethyl heterocyclic compounds | Dec 17, 2009 | Issued |
Array
(
[id] => 9608280
[patent_doc_number] => 08785445
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-22
[patent_title] => '7-phenoxychroman carboxylic acid derivatives'
[patent_app_type] => utility
[patent_app_number] => 13/141675
[patent_app_country] => US
[patent_app_date] => 2009-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47406
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13141675
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/141675 | 7-phenoxychroman carboxylic acid derivatives | Dec 17, 2009 | Issued |
Array
(
[id] => 6494425
[patent_doc_number] => 20100093746
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-15
[patent_title] => '3-(HETEROARYL-OXY)-2-ALKYL-1-AZA-BICYCLOALKYL DERIVATIVES AS ALPHA. 7-NACHR LIGANDS FOR THE TREATMENT OF CNS DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/638880
[patent_app_country] => US
[patent_app_date] => 2009-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10723
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20100093746.pdf
[firstpage_image] =>[orig_patent_app_number] => 12638880
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/638880 | 3-(heteroaryl-oxy)-2-alkyl-1-aza-bicycloalkyl derivatives as alpha. 7-nachr ligands for the treatment of CNS diseases | Dec 14, 2009 | Issued |
Array
(
[id] => 9183938
[patent_doc_number] => 08623870
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-01-07
[patent_title] => 'Pyridazinone derivatives'
[patent_app_type] => utility
[patent_app_number] => 13/143646
[patent_app_country] => US
[patent_app_date] => 2009-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17609
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13143646
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/143646 | Pyridazinone derivatives | Dec 9, 2009 | Issued |
Array
(
[id] => 7574109
[patent_doc_number] => 20110269765
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-03
[patent_title] => 'Pyridazinone derivatives'
[patent_app_type] => utility
[patent_app_number] => 13/142861
[patent_app_country] => US
[patent_app_date] => 2009-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18583
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20110269765.pdf
[firstpage_image] =>[orig_patent_app_number] => 13142861
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/142861 | Pyridazinone derivatives | Dec 9, 2009 | Issued |
Array
(
[id] => 7574111
[patent_doc_number] => 20110269767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-03
[patent_title] => 'Novel Polymorphic Forms of 3-(1--6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile Hydrochloride Salt and Processes of Manufacturing Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/143831
[patent_app_country] => US
[patent_app_date] => 2009-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 24375
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20110269767.pdf
[firstpage_image] =>[orig_patent_app_number] => 13143831
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/143831 | Polymorphic forms of 3-(1-{3-[5-(1-methyl-piperidin-4-ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile hydrochloride salt and processes of manufacturing thereof | Dec 3, 2009 | Issued |
Array
(
[id] => 8543453
[patent_doc_number] => 08318745
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-11-27
[patent_title] => 'Crystalline forms of (6R)-L-erythro-tetrahydrobiopterin dihydrochloride'
[patent_app_type] => utility
[patent_app_number] => 12/629963
[patent_app_country] => US
[patent_app_date] => 2009-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 19401
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12629963
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/629963 | Crystalline forms of (6R)-L-erythro-tetrahydrobiopterin dihydrochloride | Dec 2, 2009 | Issued |
Array
(
[id] => 7740755
[patent_doc_number] => 08106068
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-01-31
[patent_title] => 'Compositions and methods for modulating c-kit and PDGFR receptors'
[patent_app_type] => utility
[patent_app_number] => 12/629665
[patent_app_country] => US
[patent_app_date] => 2009-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36291
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/106/08106068.pdf
[firstpage_image] =>[orig_patent_app_number] => 12629665
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/629665 | Compositions and methods for modulating c-kit and PDGFR receptors | Dec 1, 2009 | Issued |
Array
(
[id] => 7511471
[patent_doc_number] => 20110257181
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-20
[patent_title] => 'PYRIDAZINONE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 13/141400
[patent_app_country] => US
[patent_app_date] => 2009-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28042
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20110257181.pdf
[firstpage_image] =>[orig_patent_app_number] => 13141400
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/141400 | Pyridazinone derivatives | Nov 23, 2009 | Issued |
Array
(
[id] => 6307191
[patent_doc_number] => 20100069405
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-18
[patent_title] => 'DERIVATIVES OF HETEROARYL-ALKYLCARBAMATES, METHODS FOR THEIR PREPARATION AND USE THEREOF AS FATTY ACID AMIDO HYDROLASE ENZYME INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/625125
[patent_app_country] => US
[patent_app_date] => 2009-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10887
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20100069405.pdf
[firstpage_image] =>[orig_patent_app_number] => 12625125
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/625125 | DERIVATIVES OF HETEROARYL-ALKYLCARBAMATES, METHODS FOR THEIR PREPARATION AND USE THEREOF AS FATTY ACID AMIDO HYDROLASE ENZYME INHIBITORS | Nov 23, 2009 | Abandoned |
Array
(
[id] => 5987166
[patent_doc_number] => 20110098304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-28
[patent_title] => 'Small molecule inhibitors of PARP activity'
[patent_app_type] => utility
[patent_app_number] => 12/592163
[patent_app_country] => US
[patent_app_date] => 2009-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 23657
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20110098304.pdf
[firstpage_image] =>[orig_patent_app_number] => 12592163
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/592163 | Small molecule inhibitors of PARP activity | Nov 18, 2009 | Abandoned |
Array
(
[id] => 4624347
[patent_doc_number] => 08003643
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-23
[patent_title] => 'Inhibitors of Akt activity'
[patent_app_type] => utility
[patent_app_number] => 12/621124
[patent_app_country] => US
[patent_app_date] => 2009-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25912
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/003/08003643.pdf
[firstpage_image] =>[orig_patent_app_number] => 12621124
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/621124 | Inhibitors of Akt activity | Nov 17, 2009 | Issued |
Array
(
[id] => 6016878
[patent_doc_number] => 20110224244
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-15
[patent_title] => 'Adamantyl Benzamide Derivatives'
[patent_app_type] => utility
[patent_app_number] => 13/128045
[patent_app_country] => US
[patent_app_date] => 2009-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14360
[patent_no_of_claims] => 82
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20110224244.pdf
[firstpage_image] =>[orig_patent_app_number] => 13128045
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/128045 | Adamantyl benzamide derivatives | Nov 16, 2009 | Issued |
Array
(
[id] => 6494667
[patent_doc_number] => 20100093765
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-15
[patent_title] => 'NOVEL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/618927
[patent_app_country] => US
[patent_app_date] => 2009-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 109825
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20100093765.pdf
[firstpage_image] =>[orig_patent_app_number] => 12618927
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/618927 | NOVEL COMPOUNDS | Nov 15, 2009 | Abandoned |
Array
(
[id] => 6494667
[patent_doc_number] => 20100093765
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-15
[patent_title] => 'NOVEL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/618927
[patent_app_country] => US
[patent_app_date] => 2009-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 109825
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20100093765.pdf
[firstpage_image] =>[orig_patent_app_number] => 12618927
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/618927 | NOVEL COMPOUNDS | Nov 15, 2009 | Abandoned |
Array
(
[id] => 6494681
[patent_doc_number] => 20100093766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-15
[patent_title] => 'NOVEL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/618933
[patent_app_country] => US
[patent_app_date] => 2009-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 109827
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20100093766.pdf
[firstpage_image] =>[orig_patent_app_number] => 12618933
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/618933 | NOVEL COMPOUNDS | Nov 15, 2009 | Abandoned |